HER-2 positivity is a high risk of recurrence of stage I gastric cancer
Background/Aims The treatment of gastric cancer remains unsatisfactory. We aimed to investigate the prognostic value of immunohistochemical staining in gastric cancer. Methods We analyzed 505 (279 early staged, 226 advanced-staged) gastric cancer tissues from patients who underwent radical gastric r...
Main Authors: | Seonhoo Kim, Yeon-Ji Kim, Woo Chul Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Association of Internal Medicine
2021-11-01
|
Series: | The Korean Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.kjim.org/upload/pdf/kjim-2020-243.pdf |
Similar Items
-
A Survey of p53 and HER-2/neu Over Expression in Patients with Gastric Cancer and Correlation with Prognosis
by: Mohammad Abbasi, et al.
Published: (2008-12-01) -
Comparison of survival outcomes between de novo and recurrent stage IV gastric cancers: A retrospective cohort study
by: Jun Ho Ji, et al.
Published: (2023-06-01) -
Detection of asymptomatic recurrence improves survival of gastric cancer patients
by: Ji Soo Park, et al.
Published: (2021-05-01) -
The Effect of Helicobacter pylori Infection on Recurrence of Gastric Hyperplastic Polyp after Endoscopic Removal
by: Kyu Ho Kang, et al.
Published: (2018-04-01) -
Clinical Outcomes of Mucinous Gastric Carcinomas Compared with Non-mucinous and Signet Ring Cell Carcinomas
by: Honggeun Ahn, et al.
Published: (2020-12-01)